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Background
Juvenile idiopathic arthritis (JIA) is a complex disease
determined by both genetic and environmental factors.
Whilst prior research has provided preliminary evidence
for some factors, most studies have been hindered by
small sample sizes and low statistical power. It is clear that
to successfully identify causal factors for complex diseases,
large sample sizes and comprehensive approaches will be
required. To this end, we have established the Victorian
JIA Biobank (VJIAB), a collaborative effort between the
Royal Children's Hospital (RCH) and the Murdoch Chil-
drens Research Institute in Melbourne Australia. Our aim
is to collect biospecimens and extensive clinical and envi-
ronmental information on 1000 cases (incident and prev-
alent, attending RCH Paediatric Rheumatology Clinic)
and 1000 controls (healthy children, matched to cases by
age and sex, attending RCH for elective surgery).
Materials and methods
The VJIAB was initiated in January 2008. A peripheral
blood sample is being collected from all participants,
from which plasma and mononuclear cells are being
banked. An extensive questionnaire that includes over
130 items is also being completed to capture information
from both parent and child on such aspects as medical
and family history, early life environment (for considera-
tion of the hygiene hypothesis), and sun exposure (for
consideration of the role of Vitamin D in the autoimmune
process).
Results and conclusion
To date, we have recruited 24 cases and matching controls.
There are also plans to extend VJIAB to capture cases Aus-
tralia-wide through the newly established Australian Pae-
diatric Rheumatology Research Network.
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